Reply to Letter to Editor from Veeravalli and Dash on "Tofacitinib Is a Mechanism-Based Inactivator of Cytochrome P450 3A4: Revisiting the Significance of the Epoxide Intermediate and Glutathione Trapping".

Chem Res Toxicol

State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.

Published: July 2020

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.chemrestox.0c00187DOI Listing

Publication Analysis

Top Keywords

reply letter
4
letter editor
4
editor veeravalli
4
veeravalli dash
4
dash "tofacitinib
4
"tofacitinib mechanism-based
4
mechanism-based inactivator
4
inactivator cytochrome
4
cytochrome p450
4
p450 3a4
4

Similar Publications

Reply: Advancing breast cancer screening through information - Theoretic approaches and AI.

Clin Imaging

December 2024

Department of Diagnostic Radiology, Singapore General Hospital, Singapore; Department of Diagnostic Radiology, Khoo Teck Puat Hospital, Singapore.

View Article and Find Full Text PDF

In Reply to the Letter to the Editor Regarding "Backup Frontal Drainage System for Urgent Tension Pneumocephalus Management After Chronic Subdural Hematoma Surgery: A Retrospective Cohort Study".

World Neurosurg

December 2024

Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, Nuevo León, México; Instituto de Neurología y Neurocirugía Centro Médico Zambrano Hellion TecSalud, Monterrey, Nuevo León, México. Electronic address:

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!